TOMI Secures Biocidal Product Approvals in Great Britain and Northern Ireland
Event summary
- TOMI's Binary Ionization Technology (BIT) and SteraMist iHP brand received biocidal product approvals from the Health and Safety Executive (HSE) in Great Britain and Northern Ireland on February 23, 2026.
- The approvals allow for room fogging and handheld direct spray applications across healthcare, industrial, commercial, hospitality, and institutional sectors.
- Elissa J. Shane, COO of TOMI, expressed optimism for pending EU Biocidal Products Regulation (BPR) approval, potentially expanding market access across Europe.
- The BIT solution is approved for disinfection of dry, pre-cleaned, hard, non-porous, non-food contact surfaces with established bactericidal, yeasticidal, and virucidal efficacy claims.
The big picture
TOMI's regulatory approvals in Great Britain and Northern Ireland mark a strategic milestone, reinforcing its commitment to compliance and safety standards. The approvals position TOMI to capitalize on the growing demand for advanced disinfection solutions across multiple sectors, particularly in the wake of heightened health and safety concerns. The pending EU BPR approval could further solidify TOMI's market presence, aligning with broader industry trends towards stringent regulatory requirements and innovative disinfection technologies.
What we're watching
- Regulatory Expansion
- Whether TOMI can secure EU Biocidal Products Regulation (BPR) approval to further expand its market reach across Europe.
- Market Penetration
- The pace at which TOMI can integrate its approved products into key sectors such as healthcare and hospitality in Great Britain and Northern Ireland.
- Competitive Positioning
- How the regulatory approvals will affect TOMI's competitive standing against other disinfection solution providers in the region.
Related topics